Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 20, 2021 - Issue 8
Submit an article Journal homepage
157
Views
8
CrossRef citations to date
0
Altmetric
Drug safety evaluation

Expert opinion on sonidegib efficacy, safety and tolerability

Alessia Villania Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalyCorrespondence[email protected]
View further author information
,
Gabriella Fabbrocinia Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalyView further author information
,
Claudia Costaa Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalyView further author information
,
Sonia Sofia Ocampo-Garzab Dermatology Department, University Hospital ¨Dr. José Eleuterio González¨, Universidad Autónoma De Nuevo León, Monterrey, MexicoView further author information
,
Aimilios Lallasc First Department of Dermatology, Aristotle University, Thessaloniki, GreeceORCID Iconhttps://orcid.org/0000-0002-7193-0964View further author information
ORCID Icon &
Massimiliano Scalvenzia Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalyView further author information
Pages 877-882 | Received 22 Jan 2021, Accepted 21 Apr 2021, Published online: 12 May 2021

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Alessia Villani, Massimiliano Scalvenzi, Giuseppe Micali, Fabrizio Martora, Francesco Cillo, Flavia Raia & Luca Potestio. (2023) An update on the current and emerging pharmacotherapies for basal cell carcinomas. Expert Opinion on Pharmacotherapy 0:0, pages 1-9.
Read now
Alessia Villani, Massimiliano Scalvenzi, Giuseppe Micali, Francesco Lacarrubba, Lucia Genco, Angelo Ruggiero, Luigi Fornaro, Gianluca Guerrasio & Luca Potestio. (2023) Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation. Expert Opinion on Drug Safety 22:7, pages 525-531.
Read now
Masoud Maleki, Pouran Layegh, Bita Kiafar, Mehrdad Teimoorian, Emadodin Darchini-Maragheh & Mahdi Razmara. (2023) Treatment of basal cell carcinoma with intralesional interferon alfa-2b: an open-label clinical trial. Expert Review of Anticancer Therapy 23:7, pages 753-760.
Read now
Kelly M Elleson, Danielle K DePalo & Jonathan S Zager. (2022) An update on local and systemic therapies for nonmelanoma skin cancer. Expert Review of Anticancer Therapy 22:5, pages 479-489.
Read now
Alessia Villani, Gabriella Fabbrocini, Francesc Di Vico, Francesca Nastro & Massimiliano Scalvenzi. (2022) Resistance to hedgehog inhibitors in basal cell carcinoma: strategies to adopt. Expert Opinion on Drug Safety 21:4, pages 583-584.
Read now

Articles from other publishers (3)

Elisa Camela, Alessia Villani, Massimiliano Scalvenzi & Claudia Costa. (2022) Giant basal cell carcinoma of the vulva successfully treated with Sonidegib. Dermatologic Therapy 35:9.
Crossref
Donatella Gambini, Emanuela Passoni, Gianluca Nazzaro, Giada Beltramini, Gianluca Tomasello, Michele Ghidini, Elisabetta Kuhn & Ornella Garrone. (2022) Basal Cell Carcinoma and Hedgehog Pathway Inhibitors: Focus on Immune Response. Frontiers in Medicine 9.
Crossref
Alessia Villani, Luca Potestio, Gabriella Fabbrocini & Massimiliano Scalvenzi. (2022) New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma. Advances in Therapy 39:3, pages 1164-1178.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.